OMID Holdings, Inc.
OMID Holdings, Inc. (OMID) Stock Competitors & Peer Comparison
See (OMID) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| OMID | $0.02 | -20.50% | 1.6M | N/A | N/A | N/A |
| STMH | $0.00 | -0.00% | 125.7B | -0.05 | -$1.89 | N/A |
| THCBF | $0.00 | +0.00% | 58.4B | -2.45 | -$0.01 | N/A |
| MKGAF | $124.50 | +1.33% | 55.8B | 17.09 | $7.51 | +1.95% |
| MKKGY | $24.69 | -2.76% | 52.6B | 16.34 | $1.54 | +1.99% |
| CHALF | $0.00 | -0.00% | 44.2B | -4.75 | -$0.08 | N/A |
| TKPHF | $27.50 | -3.71% | 42.7B | 47.16 | $0.58 | +4.87% |
| HLNCF | $4.62 | -3.45% | 42.5B | 22.51 | $0.21 | +1.90% |
| IPSEY | $30.05 | -3.31% | 41.1B | 19.91 | $1.56 | +0.84% |
| EVRRF | $0.00 | +0.00% | 25.6B | -2.40 | -$0.03 | N/A |
Stock Comparison
OMID vs STMH Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, STMH has a market cap of 125.7B. Regarding current trading prices, OMID is priced at $0.02, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas STMH's P/E ratio is -0.05. In terms of profitability, OMID's ROE is -1.36%, compared to STMH's ROE of -2.75%. Regarding short-term risk, OMID and STMH have similar daily volatility (0.00).Check STMH's competition here
OMID vs THCBF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, THCBF has a market cap of 58.4B. Regarding current trading prices, OMID is priced at $0.02, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas THCBF's P/E ratio is -2.45. In terms of profitability, OMID's ROE is -1.36%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, OMID and THCBF have similar daily volatility (0.00).Check THCBF's competition here
OMID vs MKGAF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, MKGAF has a market cap of 55.8B. Regarding current trading prices, OMID is priced at $0.02, while MKGAF trades at $124.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas MKGAF's P/E ratio is 17.09. In terms of profitability, OMID's ROE is -1.36%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, OMID is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check MKGAF's competition here
OMID vs MKKGY Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, MKKGY has a market cap of 52.6B. Regarding current trading prices, OMID is priced at $0.02, while MKKGY trades at $24.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas MKKGY's P/E ratio is 16.34. In terms of profitability, OMID's ROE is -1.36%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, OMID is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check MKKGY's competition here
OMID vs CHALF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, CHALF has a market cap of 44.2B. Regarding current trading prices, OMID is priced at $0.02, while CHALF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas CHALF's P/E ratio is -4.75. In terms of profitability, OMID's ROE is -1.36%, compared to CHALF's ROE of +0.00%. Regarding short-term risk, OMID and CHALF have similar daily volatility (0.00).Check CHALF's competition here
OMID vs TKPHF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, TKPHF has a market cap of 42.7B. Regarding current trading prices, OMID is priced at $0.02, while TKPHF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas TKPHF's P/E ratio is 47.16. In terms of profitability, OMID's ROE is -1.36%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, OMID and TKPHF have similar daily volatility (0.00).Check TKPHF's competition here
OMID vs HLNCF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, HLNCF has a market cap of 42.5B. Regarding current trading prices, OMID is priced at $0.02, while HLNCF trades at $4.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas HLNCF's P/E ratio is 22.51. In terms of profitability, OMID's ROE is -1.36%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, OMID is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check HLNCF's competition here
OMID vs IPSEY Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, IPSEY has a market cap of 41.1B. Regarding current trading prices, OMID is priced at $0.02, while IPSEY trades at $30.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas IPSEY's P/E ratio is 19.91. In terms of profitability, OMID's ROE is -1.36%, compared to IPSEY's ROE of +0.08%. Regarding short-term risk, OMID is less volatile compared to IPSEY. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check IPSEY's competition here
OMID vs EVRRF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, EVRRF has a market cap of 25.6B. Regarding current trading prices, OMID is priced at $0.02, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas EVRRF's P/E ratio is -2.40. In terms of profitability, OMID's ROE is -1.36%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, OMID and EVRRF have similar daily volatility (0.00).Check EVRRF's competition here
OMID vs SDZNY Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, SDZNY has a market cap of 24.9B. Regarding current trading prices, OMID is priced at $0.02, while SDZNY trades at $55.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas SDZNY's P/E ratio is 111.31. In terms of profitability, OMID's ROE is -1.36%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, OMID is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check SDZNY's competition here
OMID vs SRUTF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, SRUTF has a market cap of 19.6B. Regarding current trading prices, OMID is priced at $0.02, while SRUTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas SRUTF's P/E ratio is -0.09. In terms of profitability, OMID's ROE is -1.36%, compared to SRUTF's ROE of +18.75%. Regarding short-term risk, OMID is less volatile compared to SRUTF. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check SRUTF's competition here
OMID vs ESALY Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, OMID is priced at $0.02, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas ESALY's P/E ratio is 20.54. In terms of profitability, OMID's ROE is -1.36%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, OMID is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check ESALY's competition here
OMID vs TEVJF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, TEVJF has a market cap of 16.4B. Regarding current trading prices, OMID is priced at $0.02, while TEVJF trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas TEVJF's P/E ratio is -95.47. In terms of profitability, OMID's ROE is -1.36%, compared to TEVJF's ROE of -0.03%. Regarding short-term risk, OMID and TEVJF have similar daily volatility (0.00).Check TEVJF's competition here
OMID vs SGIOY Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, SGIOY has a market cap of 15.2B. Regarding current trading prices, OMID is priced at $0.02, while SGIOY trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas SGIOY's P/E ratio is 13.16. In terms of profitability, OMID's ROE is -1.36%, compared to SGIOY's ROE of +0.05%. Regarding short-term risk, OMID is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check SGIOY's competition here
OMID vs SGIOF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, SGIOF has a market cap of 14.1B. Regarding current trading prices, OMID is priced at $0.02, while SGIOF trades at $16.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas SGIOF's P/E ratio is 12.17. In terms of profitability, OMID's ROE is -1.36%, compared to SGIOF's ROE of +0.05%. Regarding short-term risk, OMID and SGIOF have similar daily volatility (0.00).Check SGIOF's competition here
OMID vs BIOVF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, BIOVF has a market cap of 10.3B. Regarding current trading prices, OMID is priced at $0.02, while BIOVF trades at $29.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas BIOVF's P/E ratio is 22.74. In terms of profitability, OMID's ROE is -1.36%, compared to BIOVF's ROE of +0.11%. Regarding short-term risk, OMID and BIOVF have similar daily volatility (0.00).Check BIOVF's competition here
OMID vs RDDTF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, RDDTF has a market cap of 9.8B. Regarding current trading prices, OMID is priced at $0.02, while RDDTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas RDDTF's P/E ratio is -0.50. In terms of profitability, OMID's ROE is -1.36%, compared to RDDTF's ROE of +0.00%. Regarding short-term risk, OMID and RDDTF have similar daily volatility (0.00).Check RDDTF's competition here
OMID vs IPSEF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, IPSEF has a market cap of 9.7B. Regarding current trading prices, OMID is priced at $0.02, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas IPSEF's P/E ratio is 18.76. In terms of profitability, OMID's ROE is -1.36%, compared to IPSEF's ROE of +0.08%. Regarding short-term risk, OMID and IPSEF have similar daily volatility (0.00).Check IPSEF's competition here
OMID vs SFOSF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, SFOSF has a market cap of 8.8B. Regarding current trading prices, OMID is priced at $0.02, while SFOSF trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas SFOSF's P/E ratio is 15.33. In terms of profitability, OMID's ROE is -1.36%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, OMID and SFOSF have similar daily volatility (0.00).Check SFOSF's competition here
OMID vs NOBDF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, NOBDF has a market cap of 8.5B. Regarding current trading prices, OMID is priced at $0.02, while NOBDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas NOBDF's P/E ratio is N/A. In terms of profitability, OMID's ROE is -1.36%, compared to NOBDF's ROE of -0.54%. Regarding short-term risk, OMID and NOBDF have similar daily volatility (0.00).Check NOBDF's competition here
OMID vs ESALF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, ESALF has a market cap of 8.5B. Regarding current trading prices, OMID is priced at $0.02, while ESALF trades at $29.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas ESALF's P/E ratio is 27.03. In terms of profitability, OMID's ROE is -1.36%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, OMID and ESALF have similar daily volatility (0.00).Check ESALF's competition here
OMID vs ESAIY Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, ESAIY has a market cap of 8.4B. Regarding current trading prices, OMID is priced at $0.02, while ESAIY trades at $7.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas ESAIY's P/E ratio is 26.57. In terms of profitability, OMID's ROE is -1.36%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, OMID is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check ESAIY's competition here
OMID vs TRLFF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, TRLFF has a market cap of 7.7B. Regarding current trading prices, OMID is priced at $0.02, while TRLFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas TRLFF's P/E ratio is -0.37. In terms of profitability, OMID's ROE is -1.36%, compared to TRLFF's ROE of +0.00%. Regarding short-term risk, OMID and TRLFF have similar daily volatility (0.00).Check TRLFF's competition here
OMID vs GZPHF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, GZPHF has a market cap of 5.9B. Regarding current trading prices, OMID is priced at $0.02, while GZPHF trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas GZPHF's P/E ratio is 10.26. In terms of profitability, OMID's ROE is -1.36%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, OMID and GZPHF have similar daily volatility (0.00).Check GZPHF's competition here
OMID vs HKMPY Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, HKMPY has a market cap of 5.3B. Regarding current trading prices, OMID is priced at $0.02, while HKMPY trades at $51.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas HKMPY's P/E ratio is 14.99. In terms of profitability, OMID's ROE is -1.36%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, OMID and HKMPY have similar daily volatility (0.00).Check HKMPY's competition here
OMID vs HKMPF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, HKMPF has a market cap of 5.3B. Regarding current trading prices, OMID is priced at $0.02, while HKMPF trades at $26.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas HKMPF's P/E ratio is 14.35. In terms of profitability, OMID's ROE is -1.36%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, OMID and HKMPF have similar daily volatility (0.00).Check HKMPF's competition here
OMID vs SGFEF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, SGFEF has a market cap of 5.2B. Regarding current trading prices, OMID is priced at $0.02, while SGFEF trades at $114.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas SGFEF's P/E ratio is 25.02. In terms of profitability, OMID's ROE is -1.36%, compared to SGFEF's ROE of +0.17%. Regarding short-term risk, OMID and SGFEF have similar daily volatility (0.00).Check SGFEF's competition here
OMID vs HLBBF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, HLBBF has a market cap of 4.8B. Regarding current trading prices, OMID is priced at $0.02, while HLBBF trades at $5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas HLBBF's P/E ratio is 11.73. In terms of profitability, OMID's ROE is -1.36%, compared to HLBBF's ROE of +0.14%. Regarding short-term risk, OMID and HLBBF have similar daily volatility (0.00).Check HLBBF's competition here
OMID vs HLUBF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, HLUBF has a market cap of 4.3B. Regarding current trading prices, OMID is priced at $0.02, while HLUBF trades at $4.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas HLUBF's P/E ratio is 8.83. In terms of profitability, OMID's ROE is -1.36%, compared to HLUBF's ROE of +0.14%. Regarding short-term risk, OMID and HLUBF have similar daily volatility (0.00).Check HLUBF's competition here
OMID vs APNHF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, APNHF has a market cap of 4.1B. Regarding current trading prices, OMID is priced at $0.02, while APNHF trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas APNHF's P/E ratio is 16.14. In terms of profitability, OMID's ROE is -1.36%, compared to APNHF's ROE of +0.05%. Regarding short-term risk, OMID and APNHF have similar daily volatility (0.00).Check APNHF's competition here
OMID vs SMDPY Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, SMDPY has a market cap of 3.9B. Regarding current trading prices, OMID is priced at $0.02, while SMDPY trades at $9.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas SMDPY's P/E ratio is 24.38. In terms of profitability, OMID's ROE is -1.36%, compared to SMDPY's ROE of +0.15%. Regarding short-term risk, OMID and SMDPY have similar daily volatility (0.00).Check SMDPY's competition here
OMID vs LVZPF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, LVZPF has a market cap of 3.8B. Regarding current trading prices, OMID is priced at $0.02, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas LVZPF's P/E ratio is 12.37. In terms of profitability, OMID's ROE is -1.36%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, OMID and LVZPF have similar daily volatility (0.00).Check LVZPF's competition here
OMID vs ULIHF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, ULIHF has a market cap of 3.5B. Regarding current trading prices, OMID is priced at $0.02, while ULIHF trades at $1.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas ULIHF's P/E ratio is 8.75. In terms of profitability, OMID's ROE is -1.36%, compared to ULIHF's ROE of +0.20%. Regarding short-term risk, OMID and ULIHF have similar daily volatility (0.00).Check ULIHF's competition here
OMID vs INVVY Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, OMID is priced at $0.02, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas INVVY's P/E ratio is -62.42. In terms of profitability, OMID's ROE is -1.36%, compared to INVVY's ROE of -0.48%. Regarding short-term risk, OMID and INVVY have similar daily volatility (0.00).Check INVVY's competition here
OMID vs IZQVF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, OMID is priced at $0.02, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, OMID's ROE is -1.36%, compared to IZQVF's ROE of -0.48%. Regarding short-term risk, OMID and IZQVF have similar daily volatility (0.00).Check IZQVF's competition here
OMID vs DNPUF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, DNPUF has a market cap of 2.9B. Regarding current trading prices, OMID is priced at $0.02, while DNPUF trades at $7.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas DNPUF's P/E ratio is 17.98. In terms of profitability, OMID's ROE is -1.36%, compared to DNPUF's ROE of +0.15%. Regarding short-term risk, OMID and DNPUF have similar daily volatility (0.00).Check DNPUF's competition here
OMID vs WIBFF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, WIBFF has a market cap of 2.9B. Regarding current trading prices, OMID is priced at $0.02, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, OMID's ROE is -1.36%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, OMID and WIBFF have similar daily volatility (0.00).Check WIBFF's competition here
OMID vs APNHY Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, APNHY has a market cap of 2.8B. Regarding current trading prices, OMID is priced at $0.02, while APNHY trades at $6.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas APNHY's P/E ratio is 11.08. In terms of profitability, OMID's ROE is -1.36%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, OMID and APNHY have similar daily volatility (0.00).Check APNHY's competition here
OMID vs HYPMY Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, HYPMY has a market cap of 2.7B. Regarding current trading prices, OMID is priced at $0.02, while HYPMY trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas HYPMY's P/E ratio is 20.49. In terms of profitability, OMID's ROE is -1.36%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, OMID is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check HYPMY's competition here
OMID vs HMDCF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, HMDCF has a market cap of 2.5B. Regarding current trading prices, OMID is priced at $0.02, while HMDCF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas HMDCF's P/E ratio is -58.00. In terms of profitability, OMID's ROE is -1.36%, compared to HMDCF's ROE of +0.03%. Regarding short-term risk, OMID and HMDCF have similar daily volatility (0.00).Check HMDCF's competition here
OMID vs HTSUF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, HTSUF has a market cap of 2.4B. Regarding current trading prices, OMID is priced at $0.02, while HTSUF trades at $28.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas HTSUF's P/E ratio is 18.24. In terms of profitability, OMID's ROE is -1.36%, compared to HTSUF's ROE of +0.08%. Regarding short-term risk, OMID and HTSUF have similar daily volatility (0.00).Check HTSUF's competition here
OMID vs CHSYF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, CHSYF has a market cap of 2.2B. Regarding current trading prices, OMID is priced at $0.02, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas CHSYF's P/E ratio is 10.34. In terms of profitability, OMID's ROE is -1.36%, compared to CHSYF's ROE of +0.10%. Regarding short-term risk, OMID and CHSYF have similar daily volatility (0.00).Check CHSYF's competition here
OMID vs SHEZF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, SHEZF has a market cap of 2.2B. Regarding current trading prices, OMID is priced at $0.02, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas SHEZF's P/E ratio is -36.03. In terms of profitability, OMID's ROE is -1.36%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, OMID and SHEZF have similar daily volatility (0.00).Check SHEZF's competition here
OMID vs CURLF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, CURLF has a market cap of 2.1B. Regarding current trading prices, OMID is priced at $0.02, while CURLF trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas CURLF's P/E ratio is -8.00. In terms of profitability, OMID's ROE is -1.36%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, OMID is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check CURLF's competition here
OMID vs DMPHF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, OMID is priced at $0.02, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, OMID's ROE is -1.36%, compared to DMPHF's ROE of +0.17%. Regarding short-term risk, OMID and DMPHF have similar daily volatility (0.00).Check DMPHF's competition here
OMID vs TSMRF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, TSMRF has a market cap of 2.1B. Regarding current trading prices, OMID is priced at $0.02, while TSMRF trades at $23.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas TSMRF's P/E ratio is 9.71. In terms of profitability, OMID's ROE is -1.36%, compared to TSMRF's ROE of +0.11%. Regarding short-term risk, OMID and TSMRF have similar daily volatility (0.00).Check TSMRF's competition here
OMID vs LBTSF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, LBTSF has a market cap of 2.1B. Regarding current trading prices, OMID is priced at $0.02, while LBTSF trades at $13.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas LBTSF's P/E ratio is 88.64. In terms of profitability, OMID's ROE is -1.36%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, OMID and LBTSF have similar daily volatility (0.00).Check LBTSF's competition here
OMID vs GTBIF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, GTBIF has a market cap of 2.1B. Regarding current trading prices, OMID is priced at $0.02, while GTBIF trades at $6.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas GTBIF's P/E ratio is 79.09. In terms of profitability, OMID's ROE is -1.36%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, OMID is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check GTBIF's competition here
OMID vs LJUIF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, OMID is priced at $0.02, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, OMID's ROE is -1.36%, compared to LJUIF's ROE of +0.15%. Regarding short-term risk, OMID and LJUIF have similar daily volatility (0.00).Check LJUIF's competition here
OMID vs CASBF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, CASBF has a market cap of 1.9B. Regarding current trading prices, OMID is priced at $0.02, while CASBF trades at $6.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas CASBF's P/E ratio is -29.81. In terms of profitability, OMID's ROE is -1.36%, compared to CASBF's ROE of -0.04%. Regarding short-term risk, OMID and CASBF have similar daily volatility (0.00).Check CASBF's competition here
OMID vs ARSUF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, OMID is priced at $0.02, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, OMID's ROE is -1.36%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, OMID and ARSUF have similar daily volatility (0.00).Check ARSUF's competition here
OMID vs NPNKF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, NPNKF has a market cap of 1.8B. Regarding current trading prices, OMID is priced at $0.02, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas NPNKF's P/E ratio is 7.95. In terms of profitability, OMID's ROE is -1.36%, compared to NPNKF's ROE of +0.14%. Regarding short-term risk, OMID and NPNKF have similar daily volatility (0.00).Check NPNKF's competition here
OMID vs EVOTF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, EVOTF has a market cap of 1.6B. Regarding current trading prices, OMID is priced at $0.02, while EVOTF trades at $8.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas EVOTF's P/E ratio is -6.73. In terms of profitability, OMID's ROE is -1.36%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, OMID and EVOTF have similar daily volatility (0.00).Check EVOTF's competition here
OMID vs MITPF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, OMID is priced at $0.02, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas MITPF's P/E ratio is -10.81. In terms of profitability, OMID's ROE is -1.36%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, OMID is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check MITPF's competition here
OMID vs TCNNF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, TCNNF has a market cap of 1.5B. Regarding current trading prices, OMID is priced at $0.02, while TCNNF trades at $5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas TCNNF's P/E ratio is -9.84. In terms of profitability, OMID's ROE is -1.36%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, OMID is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check TCNNF's competition here
OMID vs KARBF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, OMID is priced at $0.02, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas KARBF's P/E ratio is 262.50. In terms of profitability, OMID's ROE is -1.36%, compared to KARBF's ROE of N/A. Regarding short-term risk, OMID and KARBF have similar daily volatility (0.00).Check KARBF's competition here
OMID vs NPPNY Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, NPPNY has a market cap of 1.4B. Regarding current trading prices, OMID is priced at $0.02, while NPPNY trades at $5.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas NPPNY's P/E ratio is 6.35. In terms of profitability, OMID's ROE is -1.36%, compared to NPPNY's ROE of +0.05%. Regarding short-term risk, OMID and NPPNY have similar daily volatility (0.00).Check NPPNY's competition here
OMID vs CHIZF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, OMID is priced at $0.02, while CHIZF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas CHIZF's P/E ratio is 13.75. In terms of profitability, OMID's ROE is -1.36%, compared to CHIZF's ROE of +0.00%. Regarding short-term risk, OMID and CHIZF have similar daily volatility (0.00).Check CHIZF's competition here
OMID vs KSPHF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, KSPHF has a market cap of 1.3B. Regarding current trading prices, OMID is priced at $0.02, while KSPHF trades at $30.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas KSPHF's P/E ratio is 16.28. In terms of profitability, OMID's ROE is -1.36%, compared to KSPHF's ROE of +0.06%. Regarding short-term risk, OMID and KSPHF have similar daily volatility (0.00).Check KSPHF's competition here
OMID vs TWAPF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, TWAPF has a market cap of 1.2B. Regarding current trading prices, OMID is priced at $0.02, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas TWAPF's P/E ratio is 9.45. In terms of profitability, OMID's ROE is -1.36%, compared to TWAPF's ROE of +0.11%. Regarding short-term risk, OMID and TWAPF have similar daily volatility (0.00).Check TWAPF's competition here
OMID vs GNMLF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, GNMLF has a market cap of 1.2B. Regarding current trading prices, OMID is priced at $0.02, while GNMLF trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas GNMLF's P/E ratio is 11.70. In terms of profitability, OMID's ROE is -1.36%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, OMID and GNMLF have similar daily volatility (0.00).Check GNMLF's competition here
OMID vs SWGHF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, OMID is priced at $0.02, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, OMID's ROE is -1.36%, compared to SWGHF's ROE of +0.12%. Regarding short-term risk, OMID and SWGHF have similar daily volatility (0.00).Check SWGHF's competition here
OMID vs SHPHF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, SHPHF has a market cap of 1.1B. Regarding current trading prices, OMID is priced at $0.02, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas SHPHF's P/E ratio is -4.06. In terms of profitability, OMID's ROE is -1.36%, compared to SHPHF's ROE of -0.05%. Regarding short-term risk, OMID and SHPHF have similar daily volatility (0.00).Check SHPHF's competition here
OMID vs KKPCF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, OMID is priced at $0.02, while KKPCF trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas KKPCF's P/E ratio is 10.71. In terms of profitability, OMID's ROE is -1.36%, compared to KKPCF's ROE of +0.09%. Regarding short-term risk, OMID and KKPCF have similar daily volatility (0.00).Check KKPCF's competition here
OMID vs BIOGY Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, BIOGY has a market cap of 991.6M. Regarding current trading prices, OMID is priced at $0.02, while BIOGY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas BIOGY's P/E ratio is 33.66. In terms of profitability, OMID's ROE is -1.36%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, OMID and BIOGY have similar daily volatility (0.00).Check BIOGY's competition here
OMID vs NIKA Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, NIKA has a market cap of 972.7M. Regarding current trading prices, OMID is priced at $0.02, while NIKA trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas NIKA's P/E ratio is N/A. In terms of profitability, OMID's ROE is -1.36%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, OMID and NIKA have similar daily volatility (0.00).Check NIKA's competition here
OMID vs NRXCF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, NRXCF has a market cap of 842.6M. Regarding current trading prices, OMID is priced at $0.02, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, OMID's ROE is -1.36%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, OMID and NRXCF have similar daily volatility (0.00).Check NRXCF's competition here
OMID vs CSWYF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, CSWYF has a market cap of 815.8M. Regarding current trading prices, OMID is priced at $0.02, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, OMID's ROE is -1.36%, compared to CSWYF's ROE of +0.04%. Regarding short-term risk, OMID and CSWYF have similar daily volatility (0.00).Check CSWYF's competition here
OMID vs AGYTF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, AGYTF has a market cap of 757.9M. Regarding current trading prices, OMID is priced at $0.02, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas AGYTF's P/E ratio is -15.90. In terms of profitability, OMID's ROE is -1.36%, compared to AGYTF's ROE of -13.93%. Regarding short-term risk, OMID and AGYTF have similar daily volatility (0.00).Check AGYTF's competition here
OMID vs ABSCF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, ABSCF has a market cap of 732.6M. Regarding current trading prices, OMID is priced at $0.02, while ABSCF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas ABSCF's P/E ratio is -67.65. In terms of profitability, OMID's ROE is -1.36%, compared to ABSCF's ROE of +0.32%. Regarding short-term risk, OMID and ABSCF have similar daily volatility (0.00).Check ABSCF's competition here
OMID vs TRXPF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, TRXPF has a market cap of 690.8M. Regarding current trading prices, OMID is priced at $0.02, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, OMID's ROE is -1.36%, compared to TRXPF's ROE of +0.03%. Regarding short-term risk, OMID and TRXPF have similar daily volatility (0.00).Check TRXPF's competition here
OMID vs LVTTF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, LVTTF has a market cap of 661.1M. Regarding current trading prices, OMID is priced at $0.02, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, OMID's ROE is -1.36%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, OMID and LVTTF have similar daily volatility (0.00).Check LVTTF's competition here
OMID vs YIHCF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, OMID is priced at $0.02, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, OMID's ROE is -1.36%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, OMID and YIHCF have similar daily volatility (0.00).Check YIHCF's competition here
OMID vs ELTP Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, ELTP has a market cap of 605M. Regarding current trading prices, OMID is priced at $0.02, while ELTP trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas ELTP's P/E ratio is -28.25. In terms of profitability, OMID's ROE is -1.36%, compared to ELTP's ROE of -0.09%. Regarding short-term risk, OMID is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check ELTP's competition here
OMID vs TRSSF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, OMID is priced at $0.02, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, OMID's ROE is -1.36%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, OMID is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check TRSSF's competition here
OMID vs SWDCF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, SWDCF has a market cap of 600.2M. Regarding current trading prices, OMID is priced at $0.02, while SWDCF trades at $4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas SWDCF's P/E ratio is 93.88. In terms of profitability, OMID's ROE is -1.36%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, OMID and SWDCF have similar daily volatility (0.00).Check SWDCF's competition here
OMID vs AIHLF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, AIHLF has a market cap of 566M. Regarding current trading prices, OMID is priced at $0.02, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas AIHLF's P/E ratio is 12.50. In terms of profitability, OMID's ROE is -1.36%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, OMID and AIHLF have similar daily volatility (0.00).Check AIHLF's competition here
OMID vs MNFSF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, MNFSF has a market cap of 566M. Regarding current trading prices, OMID is priced at $0.02, while MNFSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas MNFSF's P/E ratio is -0.08. In terms of profitability, OMID's ROE is -1.36%, compared to MNFSF's ROE of +16.59%. Regarding short-term risk, OMID and MNFSF have similar daily volatility (0.00).Check MNFSF's competition here
OMID vs CCHWF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, OMID is priced at $0.02, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, OMID's ROE is -1.36%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, OMID is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check CCHWF's competition here
OMID vs KHTRF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, KHTRF has a market cap of 464.4M. Regarding current trading prices, OMID is priced at $0.02, while KHTRF trades at $4.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas KHTRF's P/E ratio is 66.57. In terms of profitability, OMID's ROE is -1.36%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, OMID and KHTRF have similar daily volatility (0.00).Check KHTRF's competition here
OMID vs PEXXF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, OMID is priced at $0.02, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, OMID's ROE is -1.36%, compared to PEXXF's ROE of N/A. Regarding short-term risk, OMID and PEXXF have similar daily volatility (0.00).Check PEXXF's competition here
OMID vs VRNOF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, VRNOF has a market cap of 449.6M. Regarding current trading prices, OMID is priced at $0.02, while VRNOF trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas VRNOF's P/E ratio is -1.26. In terms of profitability, OMID's ROE is -1.36%, compared to VRNOF's ROE of -0.26%. Regarding short-term risk, OMID is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check VRNOF's competition here
OMID vs BOIRF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, BOIRF has a market cap of 416.7M. Regarding current trading prices, OMID is priced at $0.02, while BOIRF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas BOIRF's P/E ratio is 31.58. In terms of profitability, OMID's ROE is -1.36%, compared to BOIRF's ROE of +0.03%. Regarding short-term risk, OMID and BOIRF have similar daily volatility (0.00).Check BOIRF's competition here
OMID vs HUMDF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, HUMDF has a market cap of 404M. Regarding current trading prices, OMID is priced at $0.02, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas HUMDF's P/E ratio is -13.69. In terms of profitability, OMID's ROE is -1.36%, compared to HUMDF's ROE of +2.11%. Regarding short-term risk, OMID and HUMDF have similar daily volatility (0.00).Check HUMDF's competition here
OMID vs LRDSF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, LRDSF has a market cap of 377.9M. Regarding current trading prices, OMID is priced at $0.02, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas LRDSF's P/E ratio is -0.03. In terms of profitability, OMID's ROE is -1.36%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, OMID and LRDSF have similar daily volatility (0.00).Check LRDSF's competition here
OMID vs CRLBF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, CRLBF has a market cap of 351.3M. Regarding current trading prices, OMID is priced at $0.02, while CRLBF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas CRLBF's P/E ratio is -7.43. In terms of profitability, OMID's ROE is -1.36%, compared to CRLBF's ROE of -0.18%. Regarding short-term risk, OMID is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check CRLBF's competition here
OMID vs EOFBF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, EOFBF has a market cap of 332.7M. Regarding current trading prices, OMID is priced at $0.02, while EOFBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas EOFBF's P/E ratio is -2.33. In terms of profitability, OMID's ROE is -1.36%, compared to EOFBF's ROE of -0.77%. Regarding short-term risk, OMID and EOFBF have similar daily volatility (0.00).Check EOFBF's competition here
OMID vs GLASF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, GLASF has a market cap of 321.8M. Regarding current trading prices, OMID is priced at $0.02, while GLASF trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas GLASF's P/E ratio is -78.44. In terms of profitability, OMID's ROE is -1.36%, compared to GLASF's ROE of +0.07%. Regarding short-term risk, OMID is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check GLASF's competition here
OMID vs ABTI Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, ABTI has a market cap of 291.9M. Regarding current trading prices, OMID is priced at $0.02, while ABTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas ABTI's P/E ratio is -20.00. In terms of profitability, OMID's ROE is -1.36%, compared to ABTI's ROE of -0.15%. Regarding short-term risk, OMID and ABTI have similar daily volatility (0.00).Check ABTI's competition here
OMID vs PKBFF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, PKBFF has a market cap of 290.5M. Regarding current trading prices, OMID is priced at $0.02, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas PKBFF's P/E ratio is N/A. In terms of profitability, OMID's ROE is -1.36%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, OMID and PKBFF have similar daily volatility (0.00).Check PKBFF's competition here
OMID vs BHHKF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, BHHKF has a market cap of 289.5M. Regarding current trading prices, OMID is priced at $0.02, while BHHKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas BHHKF's P/E ratio is -0.01. In terms of profitability, OMID's ROE is -1.36%, compared to BHHKF's ROE of -1.94%. Regarding short-term risk, OMID and BHHKF have similar daily volatility (0.00).Check BHHKF's competition here
OMID vs CPHRF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, CPHRF has a market cap of 278.8M. Regarding current trading prices, OMID is priced at $0.02, while CPHRF trades at $9.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas CPHRF's P/E ratio is 30.22. In terms of profitability, OMID's ROE is -1.36%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, OMID is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check CPHRF's competition here
OMID vs BHCCF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, BHCCF has a market cap of 243.9M. Regarding current trading prices, OMID is priced at $0.02, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas BHCCF's P/E ratio is -4.95. In terms of profitability, OMID's ROE is -1.36%, compared to BHCCF's ROE of +0.19%. Regarding short-term risk, OMID and BHCCF have similar daily volatility (0.00).Check BHCCF's competition here
OMID vs PSIQ Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, PSIQ has a market cap of 232.4M. Regarding current trading prices, OMID is priced at $0.02, while PSIQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas PSIQ's P/E ratio is N/A. In terms of profitability, OMID's ROE is -1.36%, compared to PSIQ's ROE of -1.73%. Regarding short-term risk, OMID and PSIQ have similar daily volatility (0.00).Check PSIQ's competition here
OMID vs BIOIF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, BIOIF has a market cap of 204.3M. Regarding current trading prices, OMID is priced at $0.02, while BIOIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas BIOIF's P/E ratio is -0.02. In terms of profitability, OMID's ROE is -1.36%, compared to BIOIF's ROE of -10.85%. Regarding short-term risk, OMID and BIOIF have similar daily volatility (0.00).Check BIOIF's competition here
OMID vs PLNHF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, OMID is priced at $0.02, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, OMID's ROE is -1.36%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, OMID is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check PLNHF's competition here
OMID vs YOURF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, YOURF has a market cap of 178.2M. Regarding current trading prices, OMID is priced at $0.02, while YOURF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas YOURF's P/E ratio is 0.01. In terms of profitability, OMID's ROE is -1.36%, compared to YOURF's ROE of +0.00%. Regarding short-term risk, OMID is less volatile compared to YOURF. This indicates potentially lower risk in terms of short-term price fluctuations for OMID.Check YOURF's competition here
OMID vs WLDFF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, WLDFF has a market cap of 170.2M. Regarding current trading prices, OMID is priced at $0.02, while WLDFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas WLDFF's P/E ratio is N/A. In terms of profitability, OMID's ROE is -1.36%, compared to WLDFF's ROE of -0.19%. Regarding short-term risk, OMID and WLDFF have similar daily volatility (0.00).Check WLDFF's competition here
OMID vs PHCUF Comparison August 2025
OMID plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMID stands at 1.6M. In comparison, PHCUF has a market cap of 159.9M. Regarding current trading prices, OMID is priced at $0.02, while PHCUF trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMID currently has a P/E ratio of N/A, whereas PHCUF's P/E ratio is -300.00. In terms of profitability, OMID's ROE is -1.36%, compared to PHCUF's ROE of -0.01%. Regarding short-term risk, OMID and PHCUF have similar daily volatility (0.00).Check PHCUF's competition here